Click Here to View the Activity
This educational activity is intended for cardiologists, internists, general practitioners, cardiovascular surgeons, and other health care professionals in active clinical practice involving the management of patients with cardiovascular disease.
This Webcast includes 4 remarkable presentations from the 34th Annual Williamsburg Conference on Heart Disease, which took place in Williamsburg, Virginia on December 2-4, 2007. Highlighting fascinating concepts of current management of cardiovascular disease, this online activity includes such topics as “The Emerging Role of Biomarkers in CVD: Present State and Future Challenges” and “Hyperglycemia and Acute Coronary Syndromes: A Target for Intervention?” Unanswered questions in heart failure and practical implications of chronic kidney disease as a cardiovascular risk state are also discussed in presentations included in the video.
After successful completion of this activity, participants should be able to:
- Identify current and potential biomarkers of cardiovascular disease and determine their availability for practical and clinical application
- Examine the role of comorbidities associated with cardiovascular disease, including hyperglycemia and diabetes, insulin resistance, and chronic kidney disease
- Highlight important concepts in heart failure including treatment and prevention
As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), Imedex®, LLC must ensure balance, objectivity, independence, and scientific rigor in its educational activities. Faculty are encouraged to provide a balanced view of therapeutic options by utilizing generic names of several to ensure impartiality.
All faculty participating in an Imedex activity are required to disclose commitments to and/or relationships with pharmaceutical companies, biomedical device manufacturers or distributors, or others whose products or services may be considered to be related to the subject matter of the educational activity. Disclosure of these commitments and/or relationships is included in these course materials so that participants in the activity may formulate their own judgments in interpreting its content and evaluating its recommendations.
All speakers were independently selected by the organizing committee. The following indicates the faculty disclosure declaration information and the nature of those commercial relationships.
All materials are included with the permission of the authors.
1=grant/research support 2=consultant 3=speaker’s bureau 4=stock shareholder 5=other support
| James A. de Lemos, MD |
Bayer HealthCare Corporation2; Biosite, Inc.1,2,3; Inverness
Medical Innovations, Inc2; Tethys Bioscience2 |
| William C. Roberts, MD |
Johnson & Johnson2; MERCK & CO., Inc.2,3; Novartis Pharmaceuticals Corporation3; Pfizer Inc3; Shering-Plough Corporation3 |
| Clyde W. Yancy, Jr, MD |
GlaxoSmithKline1,2,3; Medtronic, Inc.1,2; NitroMed, Inc.1,2; Novartis Pharmaceuticals Corporation3; Otsuka American Pharmaceuticals, Inc.2; Scios Inc1,2 |
The following speakers have reported an affiliation with the supporters of this conference:
| James A. de Lemos, MD |
Bristol-Myers Squibb Company3; sanofi-aventis, U.S.3 |
| Richard W. Nesto, MD |
sanofi-aventis, U.S.3 |
| William C. Roberts, MD |
AstraZeneca Pharmaceuticals LP3 |
| Clyde W. Yancy, Jr, MD |
AstraZeneca Pharmaceuticals LP2 |
The following speakers do not report any affiliation:
Peter A. McCullough, MD
Imedex, LLC Staff Disclosure of Financial Relationships
Imedex, LLC is a subsidiary of AmerisourceBergen Specialty Group, which is a subsidiary of AmerisourceBergen Company. All Imedex staff members, except for the following, who are in a position to control the content of this activity, have no financial relationships with any commercial interests that are relevant to this activity:
Keith Steward, MD, MBA, owns shares of Pfizer Inc and Johnson & Johnson, as well as stock options for AmerisourceBergen.
Chris Bolwell owns shares of GlaxoSmithKline and stock options for AmerisourceBergen.
Kenneth Richardson, MD, Bradley Bongiovanni, ND, and Becky Lynch, RN, own stock options for AmerisourceBergen.
This activity is sponsored by Imedex, LLC.
Imedex, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Imedex, LLC designates this educational activity for a maximum of 3.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
In order to receive credit, participants must successfully complete the post-test and complete the online evaluation form. You will receive an online CME statement of credit to print for your records.
For questions regarding the accreditation of this activity, please contact
Imedex
4325 Alexander Drive
Alpharetta, GA 30022
Fax: +1(770) 751-7334
Email: enduring@imedex.com
This Webcast may contain information about experimental and other uses of drugs or devices that are not currently approved by the US Food and Drug Administration (FDA) and/or other national regulatory agencies in the United States and other countries. Participants in the United States are encouraged to consult the FDA-approved product labeling for any drug or device mentioned in this program before use. Participants from other countries should consult with their respective regulatory authorities.
The opinions expressed in this Webcast are the opinions of the authors and do not necessarily reflect the opinions of Imedex.
The following companies have provided unrestricted educational grants in support of this activity: AstraZeneca Pharmaceuticals LP; Bristol-Myers Squibb Medical Imaging; Eli Lilly and Company; sanofi-aventis, U.S.
Click Here to View the Activity
 Click Here to View the Live Meeting Faculty and Agenda
|
